Hope Cancer Institute, Inc. Report issue

Academic/Hospital Phase 2
Founded: Kansas City KS United States (1997)

Organization Overview

First Clinical Trial
1997
NCT00003182
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1998

Timeline

NOW
  • Now